Dermal filler aftercare: what matters and what does not
Which post-treatment reactions are expected, which advice has reasoning behind it, and the warning signs that are not aftercare questions at all.
“Dermal filler aftercare” is a rising search, and most of what it returns is a list of prohibitions with no reasoning attached. The reasoning is the useful part, because it separates advice that matters from advice that is repeated out of habit.
What is expected
Mild swelling, redness, tenderness and small bruises at injection sites are ordinary post-injection reactions. Regulatory safety information lists bruising, swelling, erythema, pain, tenderness and itching among the common reactions, most resolving over days to weeks.
The usual pattern is that the immediate reactions settle within roughly 24 to 72 hours, with swelling largely resolving over the first week. This is why assessment of a result is conventionally deferred — judging an outcome on day two is judging oedema.
Advice with reasoning behind it
Cold, early. Cooling in short intervals in the first hours reduces swelling by vasoconstriction. This is the most mechanically obvious piece of aftercare.
Avoid exertion for a day or two. Strenuous exercise raises blood pressure and peripheral flow, which increases bruising and swelling. The recommendation is usually 24 to 48 hours.
Alcohol. A vasodilator and a mild anticoagulant; avoiding it around treatment reduces bruising. This is about bruising, not about the product.
Blood-thinning agents beforehand. Where clinically appropriate — and this is a decision for the prescriber, never a website — discontinuing agents that promote bruising in the days before treatment reduces it. Nobody should stop prescribed medication on the basis of aftercare advice.
Do not press or massage unless told to. Some products and regions call for moulding and some do not. Freelance massage risks displacing product before it has integrated.
What aftercare cannot fix
Aftercare reduces bruising and swelling. It does not change where the product was placed, and it does not prevent the complications that actually matter.
Vascular occlusion is not an aftercare problem. Blanching that follows a vessel’s territory, pain out of proportion, dusky mottled discolouration, or any visual symptom is an emergency requiring immediate contact — not a cold compress and a wait.
Delayed-onset nodules
The complication that most confuses patients, because it can appear long after everyone assumed the treatment was finished.
Delayed-onset nodules are masses arising at or near the injection site, with several possible explanations grouped under one appearance: product redistribution, delayed hypersensitivity, biofilm, or granuloma. Non-inflammatory nodules tend to appear soon after treatment and reflect placement or technique. Inflammatory ones can appear from days to more than a year later, and late reactions have been described in the months following injection.
The hypotheses discussed in the literature are the physicochemical structure of the product, infection, and an imbalance in host immune response — sometimes triggered by an unrelated illness or vaccination.
The practical implication is unglamorous but important: a lump appearing a year later is still plausibly related to the treatment, and it belongs in front of the practitioner who performed it rather than being dismissed as coincidence.
